Shares of Bionano Genomics Inc. BNGO are trading sharply higher Tuesday afternoon, expanding multi-session upside as ...

The average one-year price target for 10x Genomics (NASDAQGS:TXG) has been revised to $53.33 / share from $48.18 dated August 25, 2026, an increase of 10.70%. These figures are aggregate analyst ...

A $2.9 million R01 research award from the National Institutes of Health will support the efforts of engineers at the UC Santa Cruz Genomics Institute to further develop and drive down the cost of ...

The Genome Partnership today announced the recipients of the 2026 AGBT Precision Health Next Gen Leadership Awards, ...

Learn how to invest in the growing industry of genomics and get a list of the field's most promising companies.

Pacific salmon are integral to the livelihoods of First Nations Peoples in British Columbia, holding cultural, economic, ecological and spiritual value. This project sees that First Nations ...

The era of predictive genomics is rapidly reshaping how we think about disease, risk and lifelong health. Recent advances in whole-genome sequencing have equipped clinicians with insights into our ...

Ultima Genomics, a leader in ultra-high-throughput DNA sequencing, today announced a collaboration with NVIDIA to enable pangenome-aware whole genome sequencing (WGS) analysis at unprecedented scale.

Veracyte acquired Convergent Genomics, a bladder cancer treatment company, in a deal worth up to $180 million. The cancer diagnostics company said Monday that the deal will add Convergent's ...

Commemorating BGI Group's 27th anniversary, BGI Genomics today introduced its Digital Life Twin framework alongside an advanced multi-omics diagnostic portfolio at the 2026 Global New Product Launch ...

Genome sequencing of the rare Chinese swamp cypress shows that an ancient tree's genetic value depends on its history, not on how long it has lived.

Genomics is changing health care in Australia, offering new opportunities to prevent, diagnose and treat disease, delivering more personalised and ...